sclerosing


Also found in: Medical, Wikipedia.

scle·rose

 (sklə-rōz′, -rōs′)
v. scle·rosed, scle·ros·ing, scle·ros·es
v.tr.
To affect with sclerosis.
v.intr.
To undergo sclerosis.

[Back-formation from sclerosis.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
Translations

sclerosing

adj esclerosante
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
CM-101, is a fully humanised monoclonal antibody targeting the chemokine CCL24 that is in clinical development for the treatment of patients with liver fibrotic diseases such as NASH and Primary Sclerosing Cholangitis.
Immunic announced enrollment of the first patient in an investigator-sponsored proof-of-concept clinical trial of IMU-838 for the treatment of patients with primary sclerosing cholangitis, or PSC.
ENPNewswire-June 19, 2019--CymaBay Therapeutics Announces IND to Commence a Clinical Study of Seladelpar to Treat Primary Sclerosing Cholangitis
Note, however, that the extensive perineural spread seen in sclerosing odontogenic carcinoma does not appear to be a poor prognostic feature (Figures 4 and 5, A and B).
- Funding will Support Research to Advance Scientific Understanding and Improve Patient Care in Viral Hepatitis, Co-Infection, Nonalcoholic Steatohepatitis and Primary Sclerosing Cholangitis -
These findings led to the diagnosis of "a complex sclerosing lesion" post biopsy.
Rory has had two liver transplants in seven years after developing primary sclerosing cholangitis.
MRCP showed biliary duct beading, including the areas of strictures and focal aneurysmal dilatations of the common bile duct (CBD), consistent with sclerosing cholangitis (SC; Figure 2).
It is rarely associated with other sclerosing bone dysplasias such as melorheostosis and osteopoikilosis.
The company said HTD1801 is a new molecular entity being developed for the treatment of PSC (primary sclerosing cholangitis) and NASH.
An endoscopic retrograde cholangiopancreatography showed strictures of the common bile duct suggestive of primary sclerosing cholangitis.
However, the final pathology revealed the pulmonary sclerosing hemangioma (PSH).